Relmada Therapeutics, Inc.
DE ˙ DB ˙ US75955J4022
€ 5,30 ↓ -0.05 (-0.93%)
2026-06-04
PREÇO DA AÇÃO
SecurityDE:4E2 / Relmada Therapeutics, Inc.
InstitutionGroup One Trading, L.p.
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
Group One Trading, L.p. ownership in 4E2 / Relmada Therapeutics, Inc.

On November 12, 2025 - Group One Trading, L.p. filed a 13F-HR form disclosing ownership of 0 shares of Relmada Therapeutics, Inc. (DE:4E2) valued at $0 USD as of September 30, 2025. The entity filed a previous 13F-HR on August 14, 2025 disclosing 26,301 shares of Relmada Therapeutics, Inc.. This represents a change in shares of -100.00% during the quarter. The current value of the position is $0 USD.

Group One Trading, L.p. has a history of taking positions in derivatives of the underlying security (4E2) in the form of stock options. The firm currently holds call options representing 177,400 of underlying shares valued at $856,842 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

DE:4E2 / Relmada Therapeutics, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2025-11-12 2025-09-30 13F RELMADA THERAPEUTICS COM 75955J402 0 -26,301 -100.00 0 -100.00
2025-08-14 2025-06-30 13F RELMADA THERAPEUTICS COM 75955J402 26,301 -2,340 -8.17 16 114.29 0.0000
2025-05-14 2025-03-31 13F RELMADA THERAPEUTICS COM 75955J402 28,641 -73,446 -71.94 8 -86.79 0.0000
2025-05-14 2024-12-31 13F/A-1 RELMADA THERAPEUTICS COM 75955J402 102,087 3,142 3.18 53 -83.44 0.0001
2025-02-14 2024-12-31 13F RELMADA THERAPEUTICS COM 75955J402 102,087 3,142 53 0.0001
2024-11-14 2024-09-30 13F RELMADA THERAPEUTICS COM 75955J402 98,945 -49,982 -33.56 321 -28.25 0.0009
2024-08-14 2024-06-30 13F RELMADA THERAPEUTICS COM 75955J402 148,927 -35,411 -19.21 447 -47.96 0.0017
2024-05-10 2024-03-31 13F RELMADA THERAPEUTICS COM 75955J402 184,338 25,911 16.36 857 30.84 0.0033
2024-02-14 2023-12-31 13F RELMADA THERAPEUTICS COM 75955J402 158,427 -2,076 -1.29 656 36.17 0.0017
2023-11-09 2023-09-30 13F RELMADA THERAPEUTICS COM 75955J402 160,503 23,948 17.54 482 43.58 0.0016
2023-08-09 2023-06-30 13F RELMADA THERAPEUTICS COM 75955J402 136,555 92,861 212.53 336 241.84 0.0011
2023-05-12 2023-03-31 13F RELMADA THERAPEUTICS COM 75955J402 43,694 -99,841 -69.56 99 -80.40 0.0004
2023-02-09 2022-12-31 13F RELMADA THERAPEUTICS COM 75955J402 143,535 143,535 501 0.0012
2022-11-09 2022-09-30 13F RELMADA THERAPEUTICS COM 75955J402 0 -3,354 -100.00 0 -100.00
2022-08-11 2022-06-30 13F RELMADA THERAPEUTICS COM 75955J402 3,354 3,354 64 0.0001
2022-02-11 2021-12-31 13F RELMADA THERAPEUTICS COM 75955J402 0 -2,035 -100.00 0 -100.00
2021-11-12 2021-09-30 13F RELMADA THERAPEUTICS COM 75955J402 2,035 -5,185 -71.81 53 -77.06 0.0001
2021-08-10 2021-06-30 13F RELMADA THERAPEUTICS COM 75955J402 7,220 1,000 16.08 231 5.48 0.0003
2021-05-12 2021-03-31 13F RELMADA THERAPEUTICS COM 75955J402 6,220 6,220 219 0.0003
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-02-11 2025-12-31 13F RELMADA THERAPEUTICS COM Call 177,400 217.92 857 664.29 n/a n/a n/a
2025-11-12 2025-09-30 13F RELMADA THERAPEUTICS COM Call 55,800 129.63 112 700.00 n/a n/a n/a
2025-08-14 2025-06-30 13F RELMADA THERAPEUTICS COM Call 24,300 -66.57 15 -26.32 n/a n/a n/a
2025-05-14 2025-03-31 13F RELMADA THERAPEUTICS COM Call 72,700 -35.89 20 -67.24 n/a n/a n/a
2025-05-14 2024-12-31 13F/A RELMADA THERAPEUTICS COM Call 113,400 -29.57 59 -88.87 n/a n/a n/a
2025-02-14 2024-12-31 13F RELMADA THERAPEUTICS COM Call 113,400 59 n/a n/a n/a
2024-11-14 2024-09-30 13F RELMADA THERAPEUTICS COM Call 161,000 7,566.67 522 8,583.33 n/a n/a n/a
2024-08-14 2024-06-30 13F RELMADA THERAPEUTICS COM Call 2,100 -95.91 6 -97.49 n/a n/a n/a
2024-05-10 2024-03-31 13F RELMADA THERAPEUTICS COM Call 51,400 96.18 239 121.30 n/a n/a n/a
2024-02-14 2023-12-31 13F RELMADA THERAPEUTICS COM Call 26,200 424.00 108 620.00 n/a n/a n/a
2023-11-09 2023-09-30 13F RELMADA THERAPEUTICS COM Call 5,000 -62.41 15 -53.12 n/a n/a n/a
2023-08-09 2023-06-30 13F RELMADA THERAPEUTICS COM Call 13,300 -34.48 33 -28.89 n/a n/a n/a
2023-05-12 2023-03-31 13F RELMADA THERAPEUTICS COM Call 20,300 -93.10 46 -95.62 n/a n/a n/a
2023-02-09 2022-12-31 13F RELMADA THERAPEUTICS COM Call 294,300 -34.07 1,027 -93.79 n/a n/a n/a
2022-11-09 2022-09-30 13F RELMADA THERAPEUTICS COM Call 446,400 687.30 16,526 1,434.45 n/a n/a n/a
2022-08-11 2022-06-30 13F RELMADA THERAPEUTICS COM Call 56,700 -37.62 1,077 -56.09 n/a n/a n/a
2022-05-12 2022-03-31 13F RELMADA THERAPEUTICS COM Call 90,900 34.27 2,453 60.85 n/a n/a n/a
2022-02-11 2021-12-31 13F RELMADA THERAPEUTICS COM Call 67,700 -0.15 1,525 -14.18 n/a n/a n/a
2021-11-12 2021-09-30 13F RELMADA THERAPEUTICS COM Call 67,800 1,179.25 1,777 945.29 n/a n/a n/a
2021-08-10 2021-06-30 13F RELMADA THERAPEUTICS COM Call 5,300 -38.37 170 -43.89 n/a n/a n/a
2021-05-12 2021-03-31 13F RELMADA THERAPEUTICS COM Call 8,600 -14.00 303 -5.61 n/a n/a n/a
2021-02-10 2020-12-31 13F RELMADA THERAPEUTICS COM Call 10,000 -18.03 321 -30.07 n/a n/a n/a
2020-11-12 2020-09-30 13F RELMADA THERAPEUTICS COM Call 12,200 838.46 459 691.38 n/a n/a n/a
2020-08-13 2020-06-30 13F RELMADA THERAPEUTICS COM Call 1,300 1,200.00 58 1,833.33 n/a n/a n/a
2020-05-13 2020-03-31 13F RELMADA THERAPEUTICS COM Call 100 0.00 3 -25.00 n/a n/a n/a
2020-02-10 2019-12-31 13F RELMADA THERAPEUTICS COM Call 100 4 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2025-05-14 2025-03-31 13F RELMADA THERAPEUTICS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2025-05-14 2024-12-31 13F/A RELMADA THERAPEUTICS COM Put 22,300 93.91 12 -70.27 n/a n/a n/a
2025-02-14 2024-12-31 13F RELMADA THERAPEUTICS COM Put 22,300 12 n/a n/a n/a
2024-11-14 2024-09-30 13F RELMADA THERAPEUTICS COM Put 11,500 -34.29 37 -28.85 n/a n/a n/a
2024-08-14 2024-06-30 13F RELMADA THERAPEUTICS COM Put 17,500 -67.89 52 -79.45 n/a n/a n/a
2024-05-10 2024-03-31 13F RELMADA THERAPEUTICS COM Put 54,500 -70.41 253 -66.80 n/a n/a n/a
2024-02-14 2023-12-31 13F RELMADA THERAPEUTICS COM Put 184,200 2.16 763 41.11 n/a n/a n/a
2023-11-09 2023-09-30 13F RELMADA THERAPEUTICS COM Put 180,300 -52.61 541 -42.31 n/a n/a n/a
2023-08-09 2023-06-30 13F RELMADA THERAPEUTICS COM Put 380,500 5,753.85 936 6,585.71 n/a n/a n/a
2023-05-12 2023-03-31 13F RELMADA THERAPEUTICS COM Put 6,500 -94.14 15 -96.38 n/a n/a n/a
2023-02-09 2022-12-31 13F RELMADA THERAPEUTICS COM Put 110,900 -74.76 387 -97.62 n/a n/a n/a
2022-11-09 2022-09-30 13F RELMADA THERAPEUTICS COM Put 439,400 1,409.97 16,267 2,841.59 n/a n/a n/a
2022-08-11 2022-06-30 13F RELMADA THERAPEUTICS COM Put 29,100 1,112.50 553 750.77 n/a n/a n/a
2022-05-12 2022-03-31 13F RELMADA THERAPEUTICS COM Put 2,400 500.00 65 622.22 n/a n/a n/a
2022-02-11 2021-12-31 13F RELMADA THERAPEUTICS COM Put 400 -69.23 9 -73.53 n/a n/a n/a
2021-11-12 2021-09-30 13F RELMADA THERAPEUTICS COM Put 1,300 34 n/a n/a n/a
2020-08-13 2020-06-30 13F RELMADA THERAPEUTICS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2020-05-13 2020-03-31 13F RELMADA THERAPEUTICS COM Put 100 0.00 3 -25.00 n/a n/a n/a
2020-02-10 2019-12-31 13F RELMADA THERAPEUTICS COM Put 100 4 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.